Podocon-25 Side Effects
Generic name: podophyllum resin topical
Medically reviewed by Drugs.com. Last updated on Nov 21, 2024.
Note: This document provides detailed information about Podocon-25.
Applies to podophyllum resin topical: topical solution Side Effects associated with podophyllum resin topical. Some dosage forms listed on this page may not apply specifically to the brand name Podocon-25.
Applies to podophyllum resin topical: topical solution.
Side effects include:
Local reactions (erythema, tenderness, pruritus, burning, pain, swelling).
See also:
Aldara
Aldara (imiquimod) is used to treat actinic keratosis, basal cell carcinoma and genital warts ...
Tagamet HB
Tagamet HB is used for duodenal ulcer, duodenal ulcer prophylaxis, erosive esophagitis, GERD ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Resinol
Resinol is used for acne, dermatological disorders, eczema, psoriasis, seborrheic dermatitis
Zyclara
Zyclara (imiquimod) is used to treat actinic keratoses on the face or balding scalp and external ...
Condylox
Condylox (podofilox) is used to treat genital warts that appear on the outside of the body ...
Veregen
Veregen is used to treat external genital and anal warts in adult patients. Learn about side ...
Sinecatechins topical
Polyphenon E information from Drugs.com, includes Polyphenon E side effects interactions, indications
More about Podocon-25 (podophyllum resin topical)
- Compare alternatives
- Pricing & coupons
- Dosage information
- Drug class: topical keratolytics
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Podocon-25 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.